Perspectives on Outsourcing

Jun 01, 2005
BioPharm International
By BioPharm International Editors
Less than 35 percent of all biotech companies have sufficient finances to survive beyond one year.
Jun 01, 2005
BioPharm International
Avariety of forces are combining to fundamentally change the financial dynamics of the biopharmaceutical industry. The initial public offering (IPO) appears to be giving way to licensing arrangements with, and acquisitions by, major pharmaceutical companies.
May 01, 2005
BioPharm International
By BioPharm International Editors
Your company's job is to make biopharmaceutical products. Managing facilities is a function supporting the main task. General manufacturing companies discovered this long ago, but pharmaceutical producers have been lagging. Once you consider the outsouring of non-core activities like facility management (FM), office services, space planning, and utilities management, you can focus on core business functions that make profits.
Feb 01, 2005
BioPharm International
The contract manufacturing sector has not enjoyed the success of preclinical and clinical businesses.
Dec 01, 2004
BioPharm International
By BioPharm International Editors
Project management is a specific set of skills and processes administered to meet the specific complexities of a project.
Sep 01, 2004
BioPharm International
By BioPharm International Editors
Life sciences firms haven't exactly been jumping on the offshore outsourcing bandwagon. But faced with unprecedented cost constraints, competitive pressures, and regulatory scrutiny, the industry needs new solutions to its business problems. Some experts think information technology (IT) "offshoring" offers a solid alternative; others question the idea.
Aug 01, 2004
BioPharm International
Technology innovations aimed at increasing yields and shortening development times can be very cost-effective, promising to reduce the need for large capital investments while getting the client into the clinic much faster.
Feb 01, 2004
BioPharm International
Current productivity initiatives may be too little, too late ? a more drastic overhaul may be required.
Jan 01, 2004
BioPharm International
Biopharmaceutical companies can access their suppliers? resources to reduce validation and compliance efforts.
native1_300x100
lorem ipsum